Article
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
Rating:
0.0
Views:
26
Likes:
1
Library:
1
Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value